NantHealth (NHIQ) Competitors $0.01 0.00 (0.00%) As of 07/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NHIQ vs. SYRA, CAUD, QH, UK, MCOM, XELA, ASAP, CTK, NH, and BINIShould you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include Syra Health (SYRA), Collective Audience (CAUD), Quhuo (QH), Ucommune International (UK), Micromobility.com (MCOM), Exela Technologies (XELA), Waitr (ASAP), CooTek (Cayman) (CTK), NantHealth (NH), and Mullen Automotive (BINI). These companies are all part of the "business services" industry. NantHealth vs. Its Competitors Syra Health Collective Audience Quhuo Ucommune International Micromobility.com Exela Technologies Waitr CooTek (Cayman) NantHealth Mullen Automotive Syra Health (NASDAQ:SYRA) and NantHealth (NASDAQ:NHIQ) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings. Does the media prefer SYRA or NHIQ? In the previous week, Syra Health had 1 more articles in the media than NantHealth. MarketBeat recorded 1 mentions for Syra Health and 0 mentions for NantHealth. Syra Health's average media sentiment score of 0.13 beat NantHealth's score of 0.00 indicating that Syra Health is being referred to more favorably in the media. Company Overall Sentiment Syra Health Neutral NantHealth Neutral Is SYRA or NHIQ more profitable? NantHealth has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. NantHealth's return on equity of 0.00% beat Syra Health's return on equity.Company Net Margins Return on Equity Return on Assets Syra Health-54.90% -131.94% -99.19% NantHealth N/A N/A N/A Which has more risk and volatility, SYRA or NHIQ? Syra Health has a beta of 3.86, indicating that its stock price is 286% more volatile than the S&P 500. Comparatively, NantHealth has a beta of 24.76, indicating that its stock price is 2,376% more volatile than the S&P 500. Do insiders and institutionals believe in SYRA or NHIQ? 4.8% of Syra Health shares are owned by institutional investors. 10.2% of Syra Health shares are owned by company insiders. Comparatively, 61.3% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable valuation and earnings, SYRA or NHIQ? Syra Health has higher earnings, but lower revenue than NantHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSyra Health$7.98M0.13-$2.94M-$0.36-0.25NantHealth$67M0.01-$67.78MN/AN/A SummaryNantHealth beats Syra Health on 6 of the 11 factors compared between the two stocks. Get NantHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NHIQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NHIQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NHIQ vs. The Competition Export to ExcelMetricNantHealthData processing & preparation IndustryMedical SectorNASDAQ ExchangeMarket Cap$391K$1.28B$5.49B$9.52BDividend YieldN/A3.15%4.73%4.09%P/E RatioN/A5.3828.7823.81Price / Sales0.0122.60372.2066.04Price / CashN/A41.5135.4557.96Price / BookN/A1.138.275.54Net Income-$67.78M-$17.48M$3.25B$259.28M7 Day PerformanceN/A-3.45%-3.70%-4.64%1 Month PerformanceN/A-5.52%4.34%4.41%1 Year PerformanceN/A0.55%25.90%17.95% NantHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NHIQNantHealthN/A$0.01flatN/A-60.0%$391K$67M0.00340SYRASyra Health0.6028 of 5 stars$0.08-19.2%N/A-93.5%$907K$7.98M-0.1278Upcoming EarningsGap UpCAUDCollective AudienceN/A$0.04+0.5%N/A-91.6%$896K$12.14M0.0023QHQuhuo1.0229 of 5 stars$0.12+1.9%N/A-75.3%$722K$417.42M0.00680Gap UpHigh Trading VolumeUKUcommune International0.6145 of 5 stars$1.03-1.2%N/A-40.7%$645K$174.62M0.00510Short Interest ↑MCOMMicromobility.comN/A$0.00flatN/A-64.2%$397K$13.16M0.00360Gap DownXELAExela Technologies0.2028 of 5 stars$0.06+156.4%N/A-97.4%$382K$1.02B-0.0117,000ASAPWaitrN/AN/AN/AN/A$237K$130.00M0.00840CTKCooTek (Cayman)N/A$0.01-18.8%N/A-69.0%$97K$30.32M0.00380Gap DownHigh Trading VolumeNHNantHealth0.4378 of 5 stars$0.01flatN/A-60.0%$92K$67.68M0.00340BINIMullen AutomotiveN/A$0.04-27.8%N/A-100.0%$18K$1.09M0.00120Gap DownHigh Trading Volume Related Companies and Tools Related Companies SYRA Alternatives CAUD Alternatives QH Alternatives UK Alternatives MCOM Alternatives XELA Alternatives ASAP Alternatives CTK Alternatives NH Alternatives BINI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NHIQ) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
